Guselkumab

Common brands: Tremfya, Methotrexate, Rasuvo, Jylamvo, Otrexup

Top reporter: Janssen Biotech, Inc.

Interleukin-23 Antagonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Interleukin-17A Antagonist [EPC]Tumor Necrosis Factor Blocker [EPC]Corticosteroid [EPC]
33,064
Total Reports
25,207
Serious Reports
436
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.32%)

Patient Demographics

Male
10,867
Female
15,429

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Guselkumab.

# Reaction Reports % of Total
1 PRODUCT DOSE OMISSION ISSUE 10,625
25.9%
2 ACCIDENTAL EXPOSURE TO PRODUCT 3,315
8.1%
3 DRUG INEFFECTIVE 2,328
5.7%
4 NEEDLE ISSUE 2,164
5.3%
5 PSORIASIS 2,140
5.2%
6 DEVICE ISSUE 1,836
4.5%
7 DEVICE MALFUNCTION 1,550
3.8%
8 OFF LABEL USE 1,420
3.5%
9 PRODUCT STORAGE ERROR 1,209
3.0%
10 DEVICE DEPLOYMENT ISSUE 1,194
2.9%
11 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 942
2.3%
12 ARTHRALGIA 889
2.2%
13 DEVICE LEAKAGE 856
2.1%
14 PNEUMONIA 807
2.0%
15 DEVICE DEFECTIVE 788
1.9%
16 PRODUCT LEAKAGE 773
1.9%
17 DRUG DELIVERY SYSTEM MALFUNCTION 719
1.8%
18 UNDERDOSE 702
1.7%
19 PSORIATIC ARTHROPATHY 694
1.7%
20 PRURITUS 639
1.6%
21 PAIN 615
1.5%
22 CONDITION AGGRAVATED 607
1.5%
23 RASH 587
1.4%
24 HEADACHE 574
1.4%
25 PRODUCT DOSE OMISSION 569
1.4%
26 COVID-19 553
1.3%
27 SYRINGE ISSUE 493
1.2%
28 DIARRHOEA 469
1.1%
29 INJECTION SITE PAIN 469
1.1%
30 FATIGUE 438
1.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.